The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer

BACKGROUND & AIMS: Breast cancer (BC) is prevalent worldwide malignant cancer. Improvements in timely and effective diagnosis and prediction are needed. As reported, secreted DAND5 is contributed to BC metastasis. We aim to assess whether DAND5 in peripheral blood serum could determine BC-specif...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Chi, Yayun, Yao, Ling, Hu, Xin, Huang, Sheng, Huang, Naisi, Li, Shan, Shao, Zhiming, Wu, Jiong
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4924764/
https://ncbi.nlm.nih.gov/pubmed/26908452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7498
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars